Mouse Anti-FGF22 Recombinant Antibody (CBXF-2158) (V2LY-0925-LY1557)

Zhang, Z., Qin, Y., Ji, S., Xu, W., Liu, M., Hu, Q., ... & Xu, X. (2021). FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22/FGFR2 promotes invasion and metastasis of pancreatic cancer. Acta Biochimica et Biophysica Sinica, 53(8), 997-1008.

Zhu, S., Chen, M., Chen, M., Ye, J., Ying, Y., Wu, Q., ... & Yu, K. (2020). Fibroblast growth factor 22 inhibits ER stress-induced apoptosis and improves recovery of spinal cord injury. Frontiers in Pharmacology, 11, 18.

Castilho, A. C. S., Dalanezi, F. M., Franchi, F. F., Price, C. A., Ferreira, J. C. P., Trevisol, E., & Buratini, J. (2019). expression of fibroblast growth factor 22 (FGF22) and Its receptor, FGFR1B, during development and regression of bovine corpus luteum. Theriogenology, 125, 1-5.

Liu, H. Y., Zhao, H., & Li, W. X. (2019). Integrated analysis of transcriptome and prognosis data identifies FGF22 as a prognostic marker of lung adenocarcinoma. Technology in cancer research & treatment, 18, 1533033819827317.

Yang, H., Tian, H., Cheng, J., Zheng, J., Wang, D., Sun, C., ... & Jiang, C. (2018). Highly efficient production of functional recombinant human fibroblast growth factor 22 in E. coli and its protective effects on H2O2-lesioned L02 cells. Protein Expression and Purification, 152, 114-121.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols